Uvulopalatopharyngoplasty.
Conditions
Interventions
Intervention group: 0.5 mg/kg (maximum dose 30 mg) intravenous ketorolac half an hour before the end of surgery and then every 8 hours until 24 hours after surgery.
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: patient with american society of anesthesiologists physical status classification(ASA) BMI?35
Exclusion criteria
Exclusion criteria: heart disease uncontrolled hypertension uncontrolled diabetes gastrointestinal disease, Gastroesophageal reflux disease (GERD) Patient non-cooperation anti coagulant usage drug abuse corticosteroid usage renal disease surgery time more than 2 hr
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity, need for narcotics, time to start swallowing liquids, time to start swallowing solids. Timepoint: Number of times the need for narcotics during the first 48 hours after surgery, time to start swallowing liquids and solids, pain intensity 6, 12, 24 and 48 hours after surgery. Method of measurement: Pain intensity based on Visual Analogue Scalescale, number of times the need for narcotics, time to start swallowing liquids and solids. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate, blood pressure, slow bleeding, nausea, vomiting, rash, dizziness. Timepoint: Heart rate and blood pressure before and after induction of anesthesia, after extubation, 0, 15 and 60 minutes into recovery. Bleeding in the first 48 hours after surgery. Nausea, vomiting, rash and dizziness in the first 24 hours after surgery. Method of measurement: Heart rate per minute, blood pressure mm Hg. Bleeding, nausea and vomiting, rash and dizziness or not. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmaryam bahaloo
Yazd University of Medical Sciences
Outcome results
None listed